RecruitingPhase 2NCT06629090

Brain Blood Vessel Responses to Changes in Blood Flow: Younger Cohort

Cerebrovascular Responses to Acute Hypoperfusion


Sponsor

University of Wisconsin, Madison

Enrollment

36 participants

Start Date

Dec 17, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Brain blood flow will be measured during a simulated postural change test and while breathing increased levels of carbon dioxide using magnetic resonance imaging.


Eligibility

Min Age: 20 YearsMax Age: 40 Years

Inclusion Criteria4

  • Between the ages of 20-40 years
  • Have a BMI ≤34.5 kg/m2
  • are less than 72 in (182.88 cm) height
  • Nonsmoker

Exclusion Criteria15

  • Diagnosis of Mild Cognitive Impairment (MCI) or Alzheimer's disease (AD)
  • History or evidence of hepatic disease, hematological disease, or peripheral vascular disease; severe kidney injury requiring hemodialysis
  • History of cardiovascular disease including: severe congestive heart failure, coronary artery disease, ischemic heart disease (stents, coronary artery bypass grafts) and tachycardia
  • Uncontrolled hypertension
  • History of clinically significant ischemic or hemorrhagic stroke, or significant cerebrovascular disease
  • Severe untreated obstructive sleep apnea
  • History of diabetes with HbA1c greater than 9.5 percent
  • Major neurologic disorders other than dementia (e.g., MS, ALS, brain surgery, etc.)
  • Current or recent (less than1 year) major psychiatric condition (Axis I) or addictive disorders
  • Significant surgical history
  • Other significant medical conditions at investigators' discretion
  • Contraindications to MRI
  • Prescribed medications that interfere with prazosin
  • Lactose allergy
  • lower body will not fit in lower body negative pressure (LBNP) chamber (regardless of overall height and BMI)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMRI

Participants will undergo an MRI scan while performing breathing and simulated postural change tasks.

DRUGPrazosin

A dose of prazosin will be administered based on body weight

DRUGPlacebo

Oral placebo


Locations(1)

University of Wisconsin

Madison, Wisconsin, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06629090


Related Trials